List of Figures
Figure 1: Global CPAP Market (by End-User), $Million, 2015-2026
Figure 2: Global CPAP Market (by Region), $Million, 2015-2026
Figure 3: Key Players CPAP Revenue (Cumulative), 2015-2019
Figure 4: Global CPAP Market: Impact Analysis
Figure 5: Global CPAP Market Size COVID-19 Impact, 2020-2026
Figure 6: Global CPAP Market: Key Developments and Strategies, January 2016-February 2021
Figure 2.1: Global CPAP Market Segmentation
Figure 3.1: Global CPAP Market: Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Global CPAP Market: Bottom-Up Process 1
Figure 3.5: Global CPAP Market: Bottom-Up Process 2
Figure 3.6: Data Triangulation
Figure 3.7: Total Number of Healthcare Company Profiles
Figure 3.8: Forecast, Assumptions and Limitations
Figure 4.1: Global CPAP Market Size COVID-19 Impact, 2015-2026
Figure 4.2: Global CPAP Market: COVID-19 Impact on Volume (by Key Regions)
Figure 4.3: Potential COVID-19 Recovery Scenarios
Figure 5.1 Global Prevalence and Incidence (Obstructive Sleep Apnea), 2015-2026
Figure 5.2: North America Prevalence and Incidence (Obstructive Sleep Apnea), 2015-2026
Figure 5.3: EU5 Prevalence and Incidence (Obstructive Sleep Apnea), 2015-2026
Figure 5.4: Asia-Pacific Prevalence and Incidence (Obstructive Sleep Apnea), 2015-2026
Figure 5.5: Obstructive Sleep Apnea Prevalence (by Region), 2015-2026
Figure 5.6: Obstructive Sleep Apnea Incidence (by Region), 2015-2026
Figure 5.7: Obstructive Sleep Apnea CPAP Devices Demand, Million Units, 2015-2026
Figure 5.8: Global Prevalence and Incidence (Chronic Obstructive Respiratory Diseases), 2015-2026
Figure 5.9: North America Prevalence and Incidence (Chronic Obstructive Respiratory Diseases), 2015-2026
Figure 5.10: EU5 Prevalence and Incidence (Chronic Obstructive Respiratory Diseases), 2015-2026
Figure 5.11: Asia-Pacific Prevalence and Incidence (Chronic Obstructive Respiratory Diseases), 2015-2026
Figure 5.12: Chronic Obstructive Respiratory Diseases Prevalence (by Region), 2015-2026
Figure 5.13: Chronic Obstructive Respiratory Diseases Incidence (by Region), 2015-2026
Figure 5.14: Obstructive Sleep Apnea CPAP Devices Demand, Million Units, 2015-2026
Figure 5.15: Global Prevalence and Incidence (Neuromuscular Disorders), 2015-2026
Figure 5.16: North America Prevalence and Incidence (Neuromuscular Disorders), 2015-2026
Figure 5.17: EU5 Prevalence and Incidence (Neuromuscular Disorders), 2015-2026
Figure 5.18: Asia-Pacific Prevalence and Incidence (Neuromuscular Disorders), 2015-2026
Figure 5.19: Neuromuscular Disorders Prevalence (by Region), 2015-2026
Figure 5.20: Neuromuscular Disorders Incidence (by Region), 2015-2026
Figure 5.21: Neuromuscular Disorders CPAP Devices Demand, Units, 2015-2026
Figure 5.22: Global Prevalence and Incidence (COVID-19), January 22, 2020-January 01, 2021
Figure 5.23: North America Prevalence and Incidence (COVID-19), January 22, 2020-January 01, 2021
Figure 5.24: EU5 Prevalence and Incidence (COVID-19), January 22, 2020-January 01, 2021
Figure 5.25: Asia-Pacific Prevalence and Incidence (COVID-19), January 22, 2020-January 01, 2021
Figure 5.26: COVID-19 CPAP Devices Demand, Units, 2020-2026
Figure 5.27: Asthma Incidence Y-o-Y Analysis (by Region), 1991-2026
Figure 5.28: Asthma Incidence (by Region), 2015-2026
Figure 5.29: Asthma Prevalence Y-o-Y Analysis (by Region), 1991-2026
Figure 5.30: Asthma Prevalence (by Region), 2015-2026
Figure 5.31: Pneumoconiosis Incidence Y-o-Y Analysis (by Region), 1991-2026
Figure 5.32: Pneumoconiosis Incidence (by Region), 2015-2026
Figure 5.33: Pneumoconiosis Prevalence Y-o-Y Analysis (by Region), 1991-2026
Figure 5.34: Pneumoconiosis Prevalence (by Region), 2015-2026
Figure 5.35: Upper Respiratory Tract Infections Incidence Y-o-Y Analysis (by Region), 1991-2026
Figure 5.36: Upper Respiratory Tract Infections Incidence (by Region), 2015-2026
Figure 5.37: Upper Respiratory Tract Infections Prevalence Y-o-Y Analysis (by Region), 1991-2026
Figure 5.38: Upper Respiratory Tract Infections Prevalence (by Region), 2015-2026
Figure 5.39: Lower Respiratory Tract Infections Incidence Y-o-Y Analysis (by Region), 1991-2026
Figure 5.40: Lower Respiratory Tract Infections Incidence (by Region), 2015-2026
Figure 5.41: Lower Respiratory Tract Infections Prevalence Y-o-Y Analysis (by Region), 1991-2026
Figure 5.42: Lower Respiratory Tract Infections Prevalence (by Region), 2015-2026
Figure 5.43: Other Conditions CPAP Devices Demand, Units, 2015-2026
Figure 6.1: Global Continuous Positive Airway Pressure Market Supply Chain Analysis
Figure 6.2: Global CPAP Market: Regulatory Landscape
Figure 6.3: EU Regulatory Pathway for Medical Device
Figure 6.4: NMPA Regulatory Pathway for Medical Device
Figure 6.5: PMDA Regulatory Pathway for Medical Device
Figure 6.6: Global Continuous Positive Airway Pressure Market: Patent Analysis (by Quarters), January 2015-December 2020
Figure 7.1 Global Market Company Share Analysis (CPAP Mode Ventilator and CPAP), 2019
Figure 7.2: Regional Company Market Share (CPAP Mode Ventilators), 2019
Figure 7.3: Regional Company Market Share (CPAP), 2019
Figure 7.4 Global CPAP Market Growth Share Matrix (2015-2019)
Figure 7.5: Share of Key Developments and Strategies, January 2016-February 2021
Figure 7.6: New Offerings (by Company), January 2016-Febraury 2021
Figure 7.7: Partnerships and Alliances (by Company), January 2016-Febraury 2021
Figure 7.8: Partnerships and Alliances (by Company), January 2016-Febraury 2021
Figure 8.1: Global CPAP Market Opportunity Assessment, 2015-2026
Figure 8.2: Global CPAP Market Size and Growth Potential, $Billion, 2015-2026
Figure 8.3: Global Prevalence (Obstructive Sleep Apnea), 2015-2026
Figure 8.4: Global Sleep Apnea Prevalence (by Age Group), 2015-and 2019
Figure 8.5: Impact Analysis of Drivers of the Continuous Positive Airway Pressure (CPAP) Market
Figure 9.1: Global CPAP Market Size (Hospitals and Clinics), $Million, 2015-2026
Figure 9.2: Global CPAP Market Size (Nursing Homes), $Million, 2015-2026
Figure 9.3: Global CPAP Market Size (Elderly Care Homes), $Million, 2015-2026
Figure 9.4: Global CPAP Market Size (Home-Use), $Million, 2015-2026
Figure 10.1: Global Positive Airway Pressure Market (by Region), 2020
Figure 10.2: North America CPAP Market Size, $Million, 2015-2026
Figure 10.3: North America CPAP Market Shipments, Million Units, 2015-2026
Figure 10.4: North America CPAP Pricing Analysis, $, 2015-2026
Figure 10.5: North America Disease Prevalence, Million Cases, 2015-2026
Figure 10.6: North America CPAP Brand Share Analysis, 2019
Figure 10.7: North America CPAP Market: Key Competitors
Figure 10.8: North America CPAP Market: Company Unit Shipment and Brand Matrix, 2015-2019
Figure 10.9: U.S. CPAP Market Size, $Million, 2015-2026
Figure 10.10: U.S. Disease Prevalence, Million Cases, 2015-2026
Figure 10.11: Canada CPAP Market Size, $Million, 2015-2026
Figure 10.12 Canada Disease Prevalence, Million Cases, 2015-2026
Figure 10.13: EU5 CPAP Market Size, $Million, 2015-2026
Figure 10.14: EU5 CPAP Market Shipments, Million Units, 2015-2026
Figure 10.15: EU5 CPAP Pricing Analysis, $, 2015-2026
Figure 10.16: EU5 Disease Prevalence, Million Cases, 2015-2026
Figure 10.17: EU5 CPAP Brand Share Analysis, 2019
Figure 10.18: EU5 CPAP Market: Key Competitors
Figure 10.19: EU5 CPAP Market: Company Unit Shipment and Brand Matrix, 2015-2019
Figure 10.20: Germany CPAP Market Size, $Million, 2015-2026
Figure 10.21: Germany Disease Prevalence, Million Cases, 2015-2026
Figure 10.22: U.K. CPAP Market Size, $Million, 2015-2026
Figure 10.23: U.K. Disease Prevalence, Million Cases, 2015-2026
Figure 10.24: France CPAP Market Size, $Million, 2015-2026
Figure 10.25: France Disease Prevalence, Million Cases, 2015-2026
Figure 10.26: Italy CPAP Market Size, $Million, 2015-2026
Figure 10.27: Italy Disease Prevalence, Million Cases, 2015-2026
Figure 10.28: Spain CPAP Market Size, $Million, 2015-2026
Figure 10.29: Spain Disease Prevalence, Million Cases, 2015-2026
Figure 10.30: Asia-Pacific CPAP Market Size, $Million, 2015-2026
Figure 10.31: Asia-Pacific CPAP Market Shipments, Million Units, 2015-2026
Figure 10.32: Asia-Pacific CPAP Pricing Analysis, $, 2015-2026
Figure 10.33: Asia-Pacific Disease Prevalence, Million Cases, 2015-2026
Figure 10.34: Asia-Pacific CPAP Brand Share Analysis, 2019
Figure 10.35: Asia-Pacific CPAP Market: Key Competitors
Figure 10.36: Asia-Pacific CPAP Market: Company Unit Shipment and Brand Matrix, 2015-2019
Figure 10.37: China CPAP Market Size, $Million, 2015-2026
Figure 10.38: China Disease Prevalence, Million Cases, 2015-2026
Figure 10.39: India CPAP Market Size, $Million, 2015-2026
Figure 10.40: India Disease Prevalence, Million Cases, 2015-2026
Figure 10.41: Japan CPAP Market Size, $Million, 2015-2026
Figure 10.42: Japan Disease Prevalence, Million Cases, 2015-2026
Figure 10.43: South Korea CPAP Market Size, $Million, 2015-2026
Figure 10.44: South Korea Disease Prevalence, Million Cases, 2015-2026
Figure 10.45: Rest of Asia-Pacific CPAP Market Size, $Million, 2015-2026
Figure 10.46: Bangladesh Disease Prevalence, Million Cases, 2015-2026
Figure 10.47: Pakistan Disease Prevalence, Million Cases, 2015-2026
Figure 10.48: Malaysia Disease Prevalence, Million Cases, 2015-2026
Figure 10.49: Indonesia Disease Prevalence, Million Cases, 2015-2026
Figure 10.50: Rest-of-the-World CPAP Market Size, $Million, 2015-2026
Figure 10.51: Rest-of-the-World CPAP Market Shipments, Million Units, 2015-2026
Figure 10.52: Europe except EU5 CPAP Market Size, $Million, 2015-2026
Figure 10.53: MEA CPAP Market Size, $Million, 2015-2026
Figure 10.54: Latin America Market Size, $Million, 2015-2026
Figure 11.1: APEX MEDICAL CORP.: Overall Product Portfolio
Figure 11.2: APEX MEDICAL CORP.: SWOT Analysis
Figure 11.3: Airon Corporation: Overall Product Portfolio
Figure 11.4: Airon Corporation.: SWOT Analysis
Figure 11.5: Asahi Kasei Corporation: Overall Product Portfolio
Figure 11.6: Asahi Kasei Corporation: Overall Revenue, 2017-2019
Figure 11.7: Asahi Kasei Corporation: Revenue (by Segment), 2017-2019
Figure 11.8: Asahi Kasei Corporation: Revenue (by Region), 2017
Figure 11.9: Asahi Kasei Corporation: Revenue (by Region), 2018-2019
Figure 11.10: Asahi Kasei Corporation: SWOT Analysis
Figure 11.11: BMC Medical Co., Ltd: Overall Product Portfolio
Figure 11.12: BMC Medical Co., Ltd: SWOT
Figure 11.13: Drägerwerk AG & Co. KGaA: Overall Product Portfolio
Figure 11.14: Drägerwerk AG & Co. KGaA: Overall Financials, 2017-2019
Figure 11.15: Drägerwerk AG & Co. KGaA: Revenue (by Region), 2017-2019
Figure 11.16: Drägerwerk AG & Co. KGaA: SWOT Analysis
Figure 11.17: Fisher & Paykel Healthcare Limited: Overall Product Portfolio
Figure 11.18: Fisher & Paykel Healthcare Limited: Overall Financials, 2018-2020
Figure 11.19: Fisher & Paykel Healthcare Limited.: Revenue (by Segment), 2018-2020
Figure 11.20: Fisher & Paykel Healthcare Limited: Revenue (by Region), 2018-2020
Figure 11.21: Fisher & Paykel Healthcare Limited: SWOT Analysis
Figure 11.22: General Electric Company: Overall Product Portfolio
Figure 11.23: General Electric Company: Overall Financials, 2018-2020
Figure 11.24: General Electric Company: Revenue (by Segment), 2018-2020
Figure 11.25: General Electric Company: Revenue (by Region), 2018-2020
Figure 11.26: General Electric Company: SWOT Analysis
Figure 11.27: Getinge AB: Overall Product Portfolio
Figure 11.28: Getinge AB: Overall Financials, 2018-2020
Figure 11.29: Getinge AB: Revenue (by Segment), 2018-2020
Figure 11.30: Getinge AB: Revenue (by Region), 2018-2019
Figure 11.31: Getinge AB: SWOT Analysis
Figure 11.32: Koninklijke Philips N.V.: Overall Product Portfolio
Figure 11.33: Koninklijke Philips N.V.: Overall Financials, 2017-2019
Figure 11.34: Koninklijke Philips N.V.: Revenue (by Business Segment), 2017-2019
Figure 11.35: Koninklijke Philips N.V.: Revenue (by Region), 2017-2019
Figure 11.36: Koninklijke Philips N.V.: SWOT Analysis
Figure 11.37: Löwenstein Medical GmbH & Co. KG: Overall Product Portfolio
Figure 11.38: Lowenstein Medical GmbH & Co. KG: SWOT Analysis
Figure 11.39: Medical Depot, Inc.: Overall Product Portfolio
Figure 11.40: Medical Depot, Inc.: SWOT Analysis
Figure 11.41: Medtronic plc: Overall Product Portfolio
Figure 11.42: Medtronic plc: Overall Financials, 2018-2020
Figure 11.43: Medtronic plc: Revenue (by Segment), 2018-2020
Figure 11.44: Medtronic plc: Revenue (by Region), 2018-2020
Figure 11.45: Medtronic plc: SWOT Analysis
Figure 11.46: ResMed Inc.: Overall Product Portfolio
Figure 11.47: ResMed Inc.: Overall Financials, 2018-2020
Figure 11.48: ResMed Inc.: Revenue (by Segment), 2018-2020
Figure 11.49: ResMed Inc.: Revenue (by Region), 2018-2020
Figure 11.50: ResMed Inc.: SWOT Analysis
Figure 11.51: Smiths Group plc: Overall Product Portfolio
Figure 11.52: Smiths Group plc: Overall Financials, 2018-2020
Figure 11.53: Smiths Group plc: Revenue (by Segment), 2018-2020
Figure 11.54: Smiths Group plc: Revenue (by Region), 2018-2020
Figure 11.55: Smiths Group plc: Revenue (by Region), 2018
Figure 11.56: Smiths Group plc: Revenue (by Region), 2019-2020
Figure 11.57: Smiths Group plc: SWOT Analysis
Figure 11.58: VYAIRE MEDICAL, INC.: Overall Product Portfolio
Figure 11.59: VYAIRE MEDICAL, INC.: SWOT Analysis